Clinical trial
A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.
NCT01986114 is registered in ClinicalTrials.gov with Sumitomo Pharma Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.
- Lead sponsor
- Sumitomo Pharma Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 29, 2014
- Completion date
- February 17, 2018
- Enrollment
- 495 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar i disorder